Home - Boston Life Sciences Times

LATEST ARTICLES

Medtech

Health Tech Without Borders Launches First Global Survey on Clinical Decision-Support Tools

Life Sciences Times - September 12, 20250

Medtech

Mendaera Unveils World’s First Procedures Using Focalist Handheld Robotic System

Life Sciences Times - September 11, 20250

Pharma

Inflammasome Therapeutics’ K8 Implant Cuts Geographic Atrophy Lesion Growth by More Than 50% in Early Trial

Life Sciences Times - September 11, 20250

Biotech

Medicines Discovery Catapult and Crown Bioscience Launch Global Alliance to Advance Radiopharmaceutical Development

Life Sciences Times - September 11, 20250

Medtech

Wooster Community Hospital Cuts Nurse Documentation Time by 1,600 Hours Through MEDITECH EHR Initiative

Life Sciences Times - September 11, 20250

Pharma

Vertex Scientists Honored with 2025 Lasker~DeBakey Award for Groundbreaking Cystic Fibrosis Therapy

Life Sciences Times - September 11, 20250

People on the Move

ConcertAI Appoints Casey Graves as General Manager of Clinical Solutions

Life Sciences Times - September 11, 20250

Healthcare

South Shore Health Partners with NRC Health to Strengthen Patient and Employee Experience Strategy

Life Sciences Times - September 11, 20250

People on the Move

Takeda Appoints Rhonda Pacheco to Lead U.S. Business Unit as Julie Kim Prepares for CEO Role

Life Sciences Times - September 11, 20250

Venture Capital

Odyssey Therapeutics Secures $213 Million in Oversubscribed Series D to Advance Autoimmune Pipeline

Life Sciences Times - September 10, 20250

1...115116117...834 Page 116 of 834

Corbus Pharmaceuticals Renews Norwood Lease as It Advances Cancer and Obesity Pipeline

May 6, 2026

LTZ Therapeutics Raises $38 Million to Advance Immunotherapy Pipeline

May 6, 2026

Turbett Surgical Names Kevin Danahy President and CEO

May 6, 2026

Vertex Reaches German Reimbursement Agreement for CASGEVY

May 6, 2026

Most Popular

Corbus Pharmaceuticals Renews Norwood Lease as It Advances Cancer and Obesity Pipeline

LTZ Therapeutics Raises $38 Million to Advance Immunotherapy Pipeline

Turbett Surgical Names Kevin Danahy President and CEO

Vertex Reaches German Reimbursement Agreement for CASGEVY

Recent Comments

EDITOR PICKS

City Therapeutics Reports Preclinical Data for Stargardt Disease RNAi Therapy

Sail Biomedicines Names Gene Marcantonio Chief Medical Officer

Quiver Bioscience Receives NIH Grant to Advance Non-Opioid Chronic Pain Therapy

THIS WEEK'S STORIES

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

CellCentric Raises $220 Million to Advance Multiple Myeloma Drug Trials

Sensei Biotherapeutics Doses First Patient in Breast Cancer Trial

POPULAR CATEGORY

ABOUT US

FOLLOW US